Testing effectiveness (Phase 2)Study completedNCT01477879What this trial is testingHsv 1 and 2 Gowey Protocol Versus PlaceboWho this might be right forHerpes Naturopaths International 33
Not applicableUnknownNCT05823779What this trial is testingA 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected SubjectsWho this might be right forHIV DiseaseHerpes Simplex 1Herpes Simplex 2 Global Research Institute 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06569823What this trial is testingSafety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and OverWho this might be right forShinglesHerpes ZosterVaccine-Preventable Diseases Dynavax Technologies Corporation 764
Very early researchUnknownNCT05886075What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid TumorsWho this might be right forLung CancerBronchial CancerNon Small Cell Lung Cancer+9 more Shanghai Yunying Medical Technology 24
Testing effectiveness (Phase 2)Study completedNCT06033261What this trial is testingMRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital HerpesWho this might be right forGenital Herpes ModernaTX, Inc. 303
Early research (Phase 1)Study completedNCT02871401What this trial is testingA Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Vanderbilt University Medical Center 31
Early research (Phase 1)Study completedNCT03820414What this trial is testingSafety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult SubjectsWho this might be right forHerpes ZosterVaricella Zoster Curevo Inc 90
Large-scale testing (Phase 3)Study completedNCT01574612What this trial is testingOpen Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years OldWho this might be right forHerpes Labialis Meda Pharmaceuticals 54
Early research (Phase 1)Study completedNCT05871541What this trial is testingA First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster VaccineWho this might be right forHerpes Zoster (HZ)ShinglesInfectious Disease Immorna Biotherapeutics, Inc. 75
Post-approval studies (Phase 4)Study completedNCT00820534What this trial is testingA Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore SufferersWho this might be right forCold Sore Novartis 126
Early research (Phase 1)Study completedNCT00002116What this trial is testingA Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDSWho this might be right forHerpes SimplexHIV Infections Gilead Sciences 30
Early research (Phase 1)Study completedNCT04210752What this trial is testingStudy to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult VolunteersWho this might be right forPrevention of Herpes Zoster (HZ) EyeGene Inc. 40
Not applicableUnknownNCT04060550What this trial is testingImpact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema HerpeticumWho this might be right forAtopic Dermatitis With a History of Eczema HerpeticumAtopic Dermatitis Without a History of Eczema HerpeticumHealth Controls Without Atopy National Jewish Health 36
Early research (Phase 1)Study completedNCT05468619What this trial is testingNeonatal Phase 1 Valacyclovir StudyWho this might be right forHerpes Simplex National Institute of Allergy and Infectious Diseases (NIAID) 17
Not applicableStudy completedNCT02092233What this trial is testingA Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic PatientsWho this might be right forHerpes Luminex Corporation 1,963
Testing effectiveness (Phase 2)Looking for participantsNCT05580458What this trial is testingSafety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control PopulationWho this might be right forHerpes Zoster National Institute of Allergy and Infectious Diseases (NIAID) 225
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07227285What this trial is testingLong-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene TherapyWho this might be right forUrinary Bladder, OveractiveSpinal Cord Injury Cyllene Therapeutics 16
Not applicableStudy completedNCT04713423What this trial is testingOral and Perioral Herpes Simplex Virus Infection Type I in a Five-month-old Infant: A Case ReportWho this might be right forHerpes Simplex Virus Infection Princess Nourah Bint Abdulrahman University 1
Early research (Phase 1)Study completedNCT02579083What this trial is testingSafety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIVWho this might be right forHIVHerpes Simplex Infections KBio Inc 38
Very early researchLooking for participantsNCT06216938What this trial is testingRP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node MetastasisWho this might be right forMelanoma Yana Najjar 25